KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Non-Current Assets (2020 - 2025)

Historic Non-Current Assets for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $1.7 billion.

  • Oscar Health's Non-Current Assets fell 1419.9% to $1.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $7.8 billion, marking a year-over-year increase of 1743.22%. This contributed to the annual value of $1.7 billion for FY2025, which is 1419.9% down from last year.
  • Oscar Health's Non-Current Assets amounted to $1.7 billion in Q4 2025, which was down 1419.9% from $2.0 billion recorded in Q3 2025.
  • In the past 5 years, Oscar Health's Non-Current Assets registered a high of $2.1 billion during Q3 2024, and its lowest value of $351.8 million during Q1 2023.
  • Over the past 5 years, Oscar Health's median Non-Current Assets value was $902.8 million (recorded in 2021), while the average stood at $1.1 billion.
  • In the last 5 years, Oscar Health's Non-Current Assets tumbled by 6012.24% in 2022 and then soared by 49095.45% in 2024.
  • Oscar Health's Non-Current Assets (Quarter) stood at $1.0 billion in 2021, then plummeted by 60.12% to $405.0 million in 2022, then skyrocketed by 33.41% to $540.4 million in 2023, then surged by 269.24% to $2.0 billion in 2024, then fell by 14.2% to $1.7 billion in 2025.
  • Its Non-Current Assets was $1.7 billion in Q4 2025, compared to $2.0 billion in Q3 2025 and $2.1 billion in Q2 2025.